Study of M4344 in Combination With Niraparib
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Breast Cancer
Interventions: DRUG: Niraparib|DRUG: M4344|DRUG: Niraparib|DRUG: M4344|DRUG: Niraparib|DRUG: Niraparib
Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany